Adocia strengthens its cash position by 19 million euros following a real estate transaction

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

InflaRx Reports Full Year 2021 Financial and Operating Results

Heidelberg Pharma Announces Financial Figures for Fiscal Year 2021 and Provides Business Update

Atriva Therapeutics announces changes in its Management Team

InflaRx Receives Corrected Advice Letter from FDA Related to Phase III Program for Vilobelimab in Hidradenitis Suppurativa

Abivax reports 2021 financial results and operations update

RedHill and Kukbo Enter Oral Opaganib License for COVID-19 in South Korea

Adrenomed Supervisory Board appoints Dr. Richard Jones as CEO

Temedica announces cooperation with Bristol Myers Squibb for the development of a digital companion for psoriasis patients